Scalp Tourniquet to Lessen Alopecia after Vincristine
- 24 December 1970
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 283 (26) , 1469
- https://doi.org/10.1056/nejm197012242832620
Abstract
To the Editor: Loss of scalp hair ranging from partial to total baldness is a frequent complication of cancer chemotherapy. This may have profound psychologic effects on children, particularly adolescents, and their families. The use of wigs only partially eases the emotional distress caused by alopecia.A number of chemotherapeutic agents produce alopecia with varying degrees of regularity. The alkaloid, vincristine (Oncovin), is one of the greatest offenders, causing alopecia in 23 to 71 per cent of the patients receiving it,1 2 3 4 and hair loss has been shown to be unrelated to dose.4 Because this drug is useful in many cancers, . . .Keywords
This publication has 5 references indexed in Scilit:
- Vincristine and Prednisone for the Induction of Remissions in Acute Childhood LeukaemiaBMJ, 1969
- Vincristine in acute leukemia of childhoodCancer, 1968
- Alopecia and cytotoxic drugs.BMJ, 1966
- VINCRISTINE IN THE TREATMENT OF ACUTE LEUKEMIA IN CHILDRENPediatrics, 1966
- A PRELIMINARY INVESTIGATION OF THE FATE OF TRITIATED VINBLASTINE IN RATSCanadian Journal of Physiology and Pharmacology, 1964